Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DXCM

Dexcom Inc

Oct 30 • 04:00PM ET

68.20

+0.02 0.03 %

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO VO QQQ VUG IVV SPY VOT XLV IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	47.75	EPS (ttm)	1.43	Insider Own	1.38%	Shs Outstand	392.20M	Perf Week	-4.02%
Market Cap	26.74B	Forward P/E	26.56	EPS next Y	2.57	Insider Trans	-0.77%	Shs Float	386.73M	Perf Month	3.21%
Enterprise Value	26.39B	PEG	1.99	EPS next Q	0.67	Inst Own	93.69%	Short Float	3.00%	Perf Quarter	-13.98%
Income	571.50M	P/S	6.22	EPS this Y	25.20%	Inst Trans	-0.19%	Short Ratio	2.30	Perf Half Y	-2.93%
Sales	4.30B	P/B	10.40	EPS next Y	25.08%	ROA	8.09%	Short Interest	11.62M	Perf YTD	-12.31%
Book/sh	6.56	P/C	9.13	EPS next 5Y	23.95%	ROE	22.83%	52W High	93.25 -26.86%	Perf Year	-5.41%
Cash/sh	7.47	P/FCF	46.86	EPS past 3/5Y	41.20% 39.06%	ROIC	14.57%	52W Low	57.52 18.57%	Perf 3Y	-32.44%
Dividend Est.	-	EV/EBITDA	28.59	Sales past 3/5Y	18.10% 22.27%	Gross Margin	58.77%	Volatility	2.88% 3.05%	Perf 5Y	-33.63%
Dividend TTM	-	EV/Sales	6.14	EPS Y/Y TTM	-14.95%	Oper. Margin	15.98%	ATR (14)	2.19	Perf 10Y	242.67%
Dividend Ex-Date	-	Quick Ratio	1.35	Sales Y/Y TTM	9.30%	Profit Margin	13.29%	RSI (14)	45.71	Recom	1.45
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	27.45%	SMA20	0.54%	Beta	1.42	Target Price	97.20
Payout	0.00%	Debt/Eq	1.00	Sales Q/Q	15.21%	SMA50	-4.65%	Rel Volume	1.32	Prev Close	68.18
Employees	10300	LT Debt/Eq	0.52	Earnings	Oct 30 AMC	SMA200	-12.98%	Avg Volume	5.06M	Price	68.20
IPO	Apr 14, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.19% 2.55%	Trades		Volume	6,666,001	Change	0.03%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Resumed	Stifel	Buy	$85
Sep-08-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-21-25	Initiated	Argus	Buy	$100
Jun-16-25	Initiated	Truist	Buy	$102
May-30-25	Initiated	Goldman	Buy	$104
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500

Show Previous Ratings

Oct-30-25 11:02PM	DexCom Inc (DXCM) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Innovations (GuruFocus.com)
05:30PM	DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:10PM	DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:16PM	DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops (StockStory)
04:07PM	DexCom: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Loading…
04:02PM	Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance (Business Wire)
09:31AM	Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating (Insider Monkey)
09:23AM	Should You Buy DexCom Stock Before Oct. 31? (Motley Fool)
Oct-29-25 09:15AM	Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics (Zacks)
Oct-28-25 11:03PM	DexCom (DXCM) Reports Earnings Tomorrow: What To Expect (StockStory)
10:36AM	Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? (Zacks)
Oct-27-25 04:15PM	Dexcom Appoints Euan Ashley to Board of Directors (Business Wire)
03:06PM	Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Oct-23-25 10:00AM	DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-22-25 08:02PM	DexCom, Inc. (DXCM): A Bear Case Theory (Insider Monkey)
11:27AM	Loading…
Oct-21-25 11:27AM	Stifel resumes coverage on medtech names, sees long-term diabetes devices growth (Investing.com)
Oct-16-25 08:08AM	Here's Why Artisan Mid Cap Fund Exited Dexcom (DXCM) (Insider Monkey)
Oct-14-25 10:00AM	2 Stocks Down 17% and 21% to Buy Right Now (Motley Fool)
Oct-13-25 11:31PM	Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment (StockStory)
11:15AM	DexCom Earnings Preview: What to Expect (Barchart)
Oct-10-25 03:51PM	DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know (StockStory)
Oct-08-25 01:47AM	William Blair Maintains Bullish Stance on DexCom (DXCM) Stock (Insider Monkey)
Oct-07-25 12:35AM	1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm (StockStory)
Oct-02-25 08:30AM	Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time. (Business Wire)
Oct-01-25 07:40PM	TD Cowen Maintains its Buy Rating and $100 PT for DexCom, Inc. (DXCM) (Insider Monkey)
01:55PM	DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 (Insider Monkey)
Sep-29-25 12:56AM	UBS Downplays G7 CGM Sensor Concerns, Affirms DexCom's Inc. (DXCM) 'Buy' Rating (Insider Monkey)
Sep-26-25 11:57AM	Biolinq gets FDA de novo nod for intradermal glucose sensor (MedTech Dive)
Sep-23-25 09:45AM	1 Growth Stock Down 40% to Buy Hand Over Fist Right Now (Motley Fool)
Sep-19-25 06:59PM	Analyst Report: DexCom, Inc. (Morningstar Research) -10.99%
05:16PM	Loading…
05:16PM	S&P 500 Gains and Losses Today: Paramount Surges Amid Deal Buzz, Apple Rises as iPhone 17 Goes on Sale (Investopedia)
12:11PM	Why DexCom (DXCM) Shares Are Trading Lower Today (StockStory)
Sep-18-25 01:10PM	Insulet gets artistic with Omnipod Mango Pantone colour creation (Medical Device Network)
10:01AM	Stock Market Today: Welcome Back, 4% (TheStreet)
12:32AM	1 Large-Cap Stock Worth Your Attention and 2 We Find Risky (StockStory)
Sep-17-25 11:43AM	DexCom, Inc. (DXCM): A Bull Case Theory (Insider Monkey)
12:38AM	1 Healthcare Stock Worth Your Attention and 2 We Brush Off (StockStory)
Sep-16-25 11:42AM	Wall Street is Bullish on DexCom (DXCM), Here's Why (Insider Monkey)
07:36AM	Insulet names new CFO; Dexcom CEO on leave (MedTech Dive)
Sep-15-25 11:45AM	DexCom (DXCM) Stock Is Up, What You Need To Know (StockStory)
03:15AM	Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025 (Business Wire)
Sep-14-25 10:27AM	Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside (MarketBeat)
Sep-10-25 08:30AM	Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day (Business Wire)
Sep-09-25 03:28AM	How Is DexCom's Performance Compared to Other Medical Device Companies? (Barchart)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)
11:45AM	Why DexCom (DXCM) Shares Are Sliding Today (StockStory)
Sep-04-25 02:36PM	Why DexCom (DXCM) Stock Is Up Today (StockStory)
10:47AM	Dexcom to lay off about 350 people (MedTech Dive)
Sep-01-25 12:11PM	Investing in the Age of Longevity: Silver Economy Stocks in Focus (Zacks)
Aug-31-25 12:10AM	Argus Initiates Coverage of DexCom (DXCM) with a Buy Rating (Insider Monkey)
Aug-29-25 11:30AM	Why Is DexCom (DXCM) Down 7% Since Last Earnings Report? (Zacks)
08:21AM	If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today (Motley Fool)
Aug-28-25 04:30PM	San Diego's Dexcom lays off 350 employees (LA Times)
Aug-26-25 08:30AM	Dexcom Announces Upcoming Conference Presentations (Business Wire)
Aug-25-25 10:29AM	Stock Market Today: Stocks tumble after JPow's Friday Rally (TheStreet) -7.66%
Aug-21-25 09:36AM	CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls (The Fly)
Aug-20-25 11:20AM	DexCom Expands Access and Innovation While Balancing Headwinds (Zacks)
Aug-16-25 05:30AM	2 Stocks to Buy on the Dip and Hold for 10 Years (Motley Fool)
Aug-15-25 10:00AM	Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data (Zacks)
Aug-14-25 12:13PM	DexCom Stock: Analyst Estimates & Ratings (Barchart)
12:01AM	3 Reasons We're Fans of DexCom (DXCM) (StockStory)
Aug-13-25 09:21AM	Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk (GlobeNewswire)
12:05AM	DXCM Q2 CY2025 Deep Dive: Volume Growth, Leadership Changes, and New Product Launches Shape Outlook (StockStory)
Aug-12-25 11:38PM	5 Revealing Analyst Questions From DexCom's Q2 Earnings Call (StockStory)
06:20AM	Health Care Roundup: Market Talk (The Wall Street Journal)
03:30AM	ViCentra to Bring Smartphone-Based Closed Loop Therapy to People with Diabetes in Early 2026 (PR Newswire)
Aug-11-25 05:09PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Aug-07-25 05:39AM	Inside Dexcoms strategy to stay ahead in the $13.6bn CGM market (Medical Device Network)
Aug-06-25 07:41AM	Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It? (Zacks)
Aug-05-25 03:22PM	Dexcom's Arizona facility can service good portion of U.S. business, says CEO (CNBC TV)
01:06PM	DexCom (DXCM) Extends Losses on Day 5 Amid Leadership Change (Insider Monkey)
07:03AM	Garmin announces collaborations with leading brands for Garmin Marathon Series (PR Newswire)
Jul-31-25 04:26PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.31%
08:48AM	DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise (Zacks)
06:21AM	Dexcom Earnings Beat. Diabetes Device Maker Names New CEO. (Investor's Business Daily)
Jul-30-25 06:00PM	Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics (Zacks)
05:22PM	Dexcom Earnings Beat. Diabetes Device Maker Names New CEO. (Investor's Business Daily)
05:20PM	DexCom's (NASDAQ:DXCM) Q2 Sales Beat Estimates (StockStory)
05:15PM	DexCom (DXCM) Q2 Earnings and Revenues Top Estimates (Zacks)
04:11PM	DexCom: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan (Business Wire)
12:44PM	Dexcom CEO Kevin Sayer to step down (MedTech Dive)
08:00AM	Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program (Business Wire)
Jul-29-25 01:43PM	Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report (PR Newswire)
12:00AM	DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Jul-28-25 11:12PM	Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow (StockStory)
08:30AM	Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio (Business Wire)
Jul-25-25 11:28PM	Mizuho Lifts PT on DexCom (DXCM) to $100 From $95, Keeps an Outperform Rating (Insider Monkey)
Jul-24-25 10:15AM	Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
09:07AM	Discuss Reports Record Mid-Year Growth with AI Agentic Approach to Vibe Coding for Market Insights (GlobeNewswire)
Jul-23-25 07:45AM	Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration (Business Wire)
Jul-21-25 09:40AM	Are Medical Stocks Lagging DexCom (DXCM) This Year? (Zacks)
Jul-20-25 08:45AM	Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years (Motley Fool)
Jul-17-25 08:30AM	Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews (Business Wire)
07:33AM	Abbott beats profit estimates on medical devices demand, shares fall on forecast (Reuters)
Jul-15-25 10:00AM	Edgepark expands diabetes offerings with two new product innovations (PR Newswire)
08:45AM	Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity (PR Newswire)
Jul-14-25 12:00PM	DexCom (DXCM) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-09-25 01:30AM	DexCom Is Doubling Down on Its 'Mistake.' Why It's Time to Buy the Stock. (Barrons.com)
Jul-07-25 03:44AM	What You Need to Know Ahead of DexComs Earnings Release (Barchart)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Malady Kyle	Director	Sep 05 '25	Sale	80.86	667	53,934	22,667	Sep 09 04:18 PM
Stern Sadie	EVP, Chief HR Officer	Sep 04 '25	Sale	80.00	1,466	117,280	105,223	Sep 08 04:06 PM
Malady Kyle	Director	Sep 05 '25	Proposed Sale	80.86	667	53,934		Sep 05 11:08 AM
SADIE STERN	Officer	Sep 04 '25	Proposed Sale	80.00	1,466	117,280		Sep 04 04:29 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 02 '25	Sale	74.17	4,824	357,796	118,657	Sep 04 04:13 PM
JEREME SYLVAIN	Officer	Sep 02 '25	Proposed Sale	74.17	4,824	357,796		Sep 02 04:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 15 '25	Sale	80.29	500	40,145	94,102	Aug 18 05:56 PM
FOLETTA MARK G	Director	Aug 15 '25	Sale	81.06	2,750	222,903	51,121	Aug 18 05:53 PM
MICHAEL BROWN	Officer	Aug 15 '25	Proposed Sale	80.29	500	40,145		Aug 15 04:57 PM
FOLETTA MARK G	Director	Aug 15 '25	Proposed Sale	80.29	2,750	220,798		Aug 15 04:04 PM
Stern Sadie	EVP, Chief HR Officer	Jul 28 '25	Sale	88.99	1,466	130,459	106,689	Jul 29 04:18 PM
SADIE STERN	Officer	Jul 28 '25	Proposed Sale	88.99	1,466	130,459		Jul 28 04:29 PM
FOLETTA MARK G	Director	Jul 15 '25	Sale	85.17	2,750	234,217	53,871	Jul 17 04:08 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 15 '25	Sale	86.03	500	43,015	94,602	Jul 17 04:03 PM
MICHAEL BROWN	Officer	Jul 15 '25	Proposed Sale	86.03	500	43,015		Jul 15 04:11 PM
FOLETTA MARK G	Director	Jul 15 '25	Proposed Sale	86.03	2,750	236,582		Jul 15 04:02 PM
Stern Sadie	EVP, Chief HR Officer	Jun 26 '25	Sale	85.06	1,466	124,698	108,155	Jun 30 06:47 PM
SADIE STERN	Officer	Jun 26 '25	Proposed Sale	85.06	1,466	124,698		Jun 26 04:04 PM
FOLETTA MARK G	Director	Jun 16 '25	Sale	83.13	2,750	228,605	56,621	Jun 18 04:31 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jun 16 '25	Sale	82.80	500	41,400	95,102	Jun 18 04:31 PM
AUGUSTINOS NICHOLAS	Director	Jun 16 '25	Sale	82.80	3,672	304,042	33,411	Jun 17 05:33 PM
AUGUSTINOS NICHOLAS	Director	Jun 13 '25	Sale	81.69	2,618	213,864	37,083	Jun 17 05:33 PM
MICHAEL BROWN	Officer	Jun 16 '25	Proposed Sale	82.80	500	41,400		Jun 16 04:12 PM
FOLETTA MARK G	Director	Jun 16 '25	Proposed Sale	82.80	2,750	227,700		Jun 16 04:02 PM
AUGUSTINOS NICHOLAS	Director	Jun 09 '25	Proposed Sale	86.91	6,290	546,664		Jun 09 03:59 PM
Stern Sadie	EVP, Chief HR Officer	May 27 '25	Sale	85.11	6,184	526,318	109,621	May 28 04:51 PM
Brown Michael Jon	EVP, Chief Legal Officer	May 23 '25	Sale	84.28	10,000	842,849	95,602	May 28 04:50 PM
SADIE STERN	Officer	May 27 '25	Proposed Sale	85.11	6,184	526,318		May 27 04:18 PM
MICHAEL BROWN	Officer	May 23 '25	Proposed Sale	84.28	10,000	842,849		May 23 04:04 PM
Heller Bridgette P	Director	Mar 17 '25	Sale	70.33	352	24,756	22,997	Mar 19 05:02 PM
Heller Bridgette P	Director	Mar 17 '25	Proposed Sale	70.33	352	24,756		Mar 17 09:40 AM
Leach Jacob Steven	EVP, Chief Operating Officer	Mar 12 '25	Sale	70.38	14,076	990,670	313,497	Mar 14 05:25 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 12 '25	Sale	70.38	13,000	914,941	105,602	Mar 14 05:25 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 12 '25	Sale	70.38	12,001	844,632	123,481	Mar 14 05:25 PM
Stern Sadie	EVP, Chief HR Officer	Mar 12 '25	Sale	70.38	11,176	786,568	115,805	Mar 14 05:25 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 12 '25	Sale	70.38	32,498	2,287,212	372,029	Mar 14 05:24 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 10 '25	Sale	73.83	7,000	516,830	135,482	Mar 11 07:17 PM
JEREME SYLVAIN	Officer	Mar 10 '25	Proposed Sale	73.83	7,000	516,830		Mar 10 04:03 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Jan 29 '25	Sale	86.91	2,090	181,650	83,526	Jan 30 06:44 PM
Dolan Matthew Vincent	EVP, Strategy & Corporate Dev	Jan 29 '25	Sale	86.91	1,183	102,820	42,044	Jan 30 06:44 PM
Stern Sadie	EVP, Chief HR Officer	Jan 29 '25	Sale	86.91	2,093	181,911	74,261	Jan 30 06:44 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Jan 29 '25	Sale	86.91	2,634	228,932	268,644	Jan 30 06:44 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 29 '25	Sale	86.91	33,359	2,899,367	319,037	Jan 30 06:43 PM
Stern Sadie	EVP, Chief HR Officer	Dec 16 '24	Sale	76.87	424	32,593	70,768	Dec 17 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Dec 16 '24	Sale	76.87	744	57,191	80,030	Dec 17 04:15 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Dec 16 '24	Sale	76.87	744	57,191	264,171	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Sale	76.87	1,000	76,870	23,349	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Proposed Sale	76.87	1,000	76,870		Dec 16 11:56 AM
Stern Sadie	EVP, Chief HR Officer	Nov 20 '24	Sale	74.73	4,259	318,275	71,192	Nov 22 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Nov 15 '24	Sale	75.51	3,500	264,285	80,774	Nov 18 04:12 PM
JEREME SYLVAIN	Officer	Nov 15 '24	Proposed Sale	75.51	3,500	264,285		Nov 15 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience